View in EDS

Ribociclib is not a substrate or inhibitor of Oatp1b-mediated uptake in vivo.

Saved in:
Bibliographic Details
Title: Ribociclib is not a substrate or inhibitor of Oatp1b-mediated uptake in vivo.
Authors: Drabison T; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Ahmed EA; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Colasanti N; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Weber RH; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Sparreboom A; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA.; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Eisenmann ED; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA. Eisenmann.11@osu.edu.; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Eisenmann.11@osu.edu.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Apr 07; Vol. 96 (1). Date of Electronic Publication: 2026 Apr 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0843
DOI:10.1007/s00280-026-04877-x